Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
Recruiting · NCT06414096 · Registry updated 2024-11-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome | Body Weight, Genital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, infertility disorder, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2024-11-27 | NCT06414096 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Colorado, Denver | 475 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora | United States | 142 |